Nurix insider reports RSU vesting and tax sell-to-cover
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics (NRIX) reported insider activity by its Chief Legal Officer, Christine Ring. On 10/30/2025, multiple restricted stock unit (RSU) vestings converted into common stock via code “M” totaling 10,532 shares (1,924; 2,000; 3,750; 2,858), each at $0 per the RSU terms. A subsequent sale of 3,644 shares at a weighted average price of $12.7967 was executed to cover tax withholding obligations under a required “sell-to-cover” arrangement.
Following these transactions, the reporting person held 50,897 shares directly. Each RSU represents a right to receive one share upon vesting, with tranches vesting quarterly pursuant to previously granted awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,644 shares ($46,631)
Net Sell
9 txns
Insider
Ring Christine
Role
Chief Legal Officer
Sold
3,644 shs ($47K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,924 | $0.00 | -- |
| Exercise | Restricted Stock Units | 2,000 | $0.00 | -- |
| Exercise | Restricted Stock Units | 3,750 | $0.00 | -- |
| Exercise | Restricted Stock Units | 2,858 | $0.00 | -- |
| Exercise | Common Stock | 1,924 | $0.00 | -- |
| Exercise | Common Stock | 2,000 | $0.00 | -- |
| Exercise | Common Stock | 3,750 | $0.00 | -- |
| Exercise | Common Stock | 2,858 | $0.00 | -- |
| Sale | Common Stock | 3,644 | $12.7967 | $47K |
Holdings After Transaction:
Restricted Stock Units — 1,925 shares (Direct);
Common Stock — 45,933 shares (Direct)
Footnotes (1)
- The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Represents the weighted average sale price. The lowest price at which shares were sold was $12.68 and the highest price at which shares were sold was $12.89. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in substantially equal increments quarterly over four years, with the first quarterly increment vesting on April 30, 2022, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. RSUs do not expire; they either vest or are canceled prior to the vest date. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2023, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2024, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2025, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
FAQ
What insider transaction did NRIX report on Form 4?
The Chief Legal Officer reported RSU vestings converting 10,532 shares and a sale of 3,644 shares to cover taxes.
What were the RSU conversion details?
RSUs converted to common stock via code “M” in amounts of 1,924; 2,000; 3,750; and 2,858 shares, each at $0 per RSU terms.
Who is the reporting person and their role at NRIX?
Christine Ring, the company’s Chief Legal Officer.
Do RSUs in this report expire?
RSUs do not expire; they either vest or are canceled prior to the vest date.